Article Information
PubMed
Print ISSN
Online ISSN
History
- Received September 17, 2013
- Accepted January 6, 2014
- Published online February 12, 2014.
Article Versions
- Earlier version (January 6, 2014 - 08:05).
- Earlier version (January 6, 2014 - 08:51).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Gunilla Englund,
- Patrik Lundquist,
- Cristine Skogastierna,
- Jenny Johansson,
- Janet Hoogstraate,
- Lovisa Afzelius,
- Tommy B. Andersson, and
- Denis Projean
- CNS and Pain Innovative Medicines DMPK, AstraZeneca R&D, Södertälje (G.E., P.L., C.S., J.J., J.H., L.A.); Cardiovascular and Metabolic Diseases Innovative Medicines DMPK, AstraZeneca R&D, Mölndal (P.L., T.B.A., D.P.); Department of Pharmacy, Uppsala University, Uppsala (P.L.); and Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm (T.B.A.), Sweden
- Address correspondence to:
Tommy B. Andersson, Cardiovascular and Metabolic Diseases Innovative Medicines DMPK, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden. E-mail: tommy.b.andersson{at}astrazeneca.com
Statistics from Altmetric.com
Article usage
In this issue
P450 Inhibition by Efflux Transporter Inhibitors
